It looks like Nina & team will not hold back signing any new deals either before or after March. Rightly so. Bird in hand is better than many in the bush. It only brings in more confidence to the entire team. It adds to those who contribute to its success in one way or the other. Pharma companies that sign up will not just pay and sit around. They will use their expertise that they would have gained from their past experiences. It will be invaluable as our team probably will be first to many of these formalities etc.
I would not be surprised if I see at least one more sign up before Christmas or March. Other than regular hiccups, this SP has green written all over it.
Ann: ACTION3 IND Approved in China, page-19
-
- There are more pages in this discussion • 213 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
0.055(9.91%) |
Mkt cap ! $335.3M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 61.5¢ | 56.5¢ | $1.938M | 3.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3652 | 60.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 27035 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |